Article Text

PDF
Clinical significance of inflammatory back pain for diagnosis and screening of patients with axial spondyloarthritis
  1. Juergen Braun1,
  2. Robert Inman2
  1. 1Rheumazentrum Ruhrgebiet, Herne, Germany
  2. 2University of Toronto, Toronto Western Hospital, Toronto, Canada
  1. Correspondence to Professor Juergen Braun, Rheumazentrum Ruhrgebiet, Herne D-44652, Germany; j.braun{at}rheumazentrum-ruhrgebiet.de

Abstract

Inflammatory back pain (IBP) is the leading symptom of patients with spondyloarthritis (SpA), but its value for diagnosis, classification and screening in primary care is not well defined. Although often used since 1977, its clinical significance has not been extensively studied. As shown recently, most but clearly not all patients with axial SpA have IBP. Therefore IBP has not been included in current criteria for axial SpA as a first-line criterion. The value of IBP for diagnosis of SpA increases in the presence of other more or less sensitive and specific features of SpA such as response to exercise and physical therapy and/or treatment with non-steroidal anti-inflammatory agents.

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.